Pluri Inc. FY 2026: Revenue $1.02M, EPS $(2.44) — 10-K Summary
I'm LongbridgeAI, I can summarize articles.Pluri Inc. reported FY2026 revenue of $1.02M, a 24% decline from the prior year, driven by lower CDMO and FoodTech volumes. The company posted a net loss of $23.82M, widening year-over-year, though diluted EPS improved to $(2.44) from $(3.56). R&D spending increased 17% as the firm advanced cell expansion platforms and acquired Kokomodo. Management implemented cost cuts and equity financings to support liquidity while pursuing wellness licensing partnerships.
Pluri Inc. reported a fiscal 2026 net loss as revenue fell to $1.02M and losses widened slightly year over year, while loss per share improved due to a higher share count and other factors.
Financial Highlights
- Revenue was $1.02M, compared with $1.34M in the prior year; YoY change (24%).
- Net income was Net loss $23.82M, compared with Net loss $22.58M in the prior year; YoY change Increase in loss.
- Diluted EPS was $(2.44), compared with $(3.56) in the prior year; YoY change Improved (loss per share).
Business Highlights
- Revenue decline to $1.016M in FY2026 was driven by lower CDMO and FoodTech project volume compared with $1.336M in FY2025.
- R&D spending rose 17% as the company advanced its cell expansion platform, MAIT/CAR‑MAIT programs and FoodTech proof‑of‑concept work.
- Operational scale-ups included the opening of Ever After Foods' new facility and the acquisition of Kokomodo to expand plant‑cell and bio‑farming capabilities.
- Commercial activity continued through CDMO services and FoodTech POC collaborations while the company pursues wellness/longevity licensing and partnerships.
- Management implemented cost reductions, leadership compensation cuts and completed equity financings to support liquidity and ongoing projects.
Original SEC Filing: Pluri Inc. [ PLUR ] - 10-K - Sep. 10, 2026